Position in EXEL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,923,448
+$1,478,611 QoQ
Shares Held
91,477
+64.0% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GUGGENHEIM CAPITAL LLC holds $203,614,751 across 74 Biotechnology names. EXEL ranks #8 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
100,386 | $44,826,363 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
42,909 | $33,153,208 | |
| 3 | INSM |
INSMED Inc
|
80,021 | $13,085,033 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
37,114 | $12,279,909 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
91,463 | $5,734,729 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
68,749 | $4,443,247 | |
| 7 | INCY |
Incyte Corp
|
44,622 | $4,199,821 | |
| 8 | EXEL |
Exelixis, Inc.
This page
|
91,477 | $3,923,448 |
All Filings in EXEL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,923,448 | 91,477 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,444,837 | 55,780 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,460,240 | 59,570 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,672,746 | 60,634 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $2,530,053 | 68,528 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $2,495,901 | 74,952 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,901,391 | 111,807 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,819,176 | 125,464 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $6,539,915 | 275,597 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $4,378,990 | 182,534 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $4,820,742 | 220,629 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $4,330,172 | 226,592 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $4,580,856 | 236,005 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $3,791,470 | 236,376 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,721,365 | 237,332 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,006,252 | 240,454 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $5,703,703 | 251,597 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,830,525 | 264,252 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $7,121,219 | 336,860 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $5,753,529 | 315,781 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $6,454,075 | 285,705 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $5,692,654 | 283,640 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $6,112,328 | 249,993 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $7,125,726 | 300,157 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $4,580,932 | 266,024 | Shares | Defined | 2020-06-02 | |
| No filing history on record for this holder in this stock. | ||||||